Investment Thesis
Concentra demonstrates solid operational growth with 13.9% revenue expansion and a reasonable 16.8% operating margin, but faces significant financial stress from excessive leverage (3.68x Debt/Equity) and critically weak cash conversion (only $9.9M FCF on $50.5M net income). The declining EPS despite revenue growth signals margin compression, while minimal liquidity ($61.7M cash vs. $1.6B long-term debt) creates vulnerability to operational setbacks.
Strengths
- Strong revenue growth of 13.9% YoY demonstrates market demand and operational scale
- Operating margin of 16.8% is reasonable for specialty outpatient facilities sector
- Positive and growing operating income of $95.6M provides operational cash generation foundation
Risks
- Excessive leverage with 3.68x Debt/Equity ratio and $1.6B long-term debt against only $424.7M equity creates significant financial instability risk
- Critical cash flow weakness: only $21M operating cash flow on $50.5M net income indicates poor earnings quality and debt service vulnerability
- Diluted EPS declined 11.0% YoY despite 13.9% revenue growth, signaling margin compression and/or shareholder dilution from capital structure
- Severe liquidity constraint with just $61.7M cash and 1.26x current ratio limits financial flexibility and debt repayment capacity
- Extremely low ROA of 1.7% and weak FCF margin of 1.7% suggest operational efficiency challenges relative to asset base
Key Metrics to Watch
- Operating Cash Flow and Free Cash Flow margin trend - critical indicator of debt service sustainability and business model health
- Debt/Equity ratio and absolute debt levels - must monitor deleveraging progress to reduce financial risk
- Net Income growth rate vs. Revenue growth rate - watch for continued margin compression or stabilization
- Cash balance and liquidity metrics - any decline would materially worsen financial distress risk
Financial Metrics
Revenue
569.6M
Net Income
50.5M
EPS (Diluted)
$0.39
Free Cash Flow
9.9M
Total Assets
2.9B
Cash
61.7M
Profitability Ratios
Gross Margin
N/A
Operating Margin
16.8%
Net Margin
8.9%
ROE
11.9%
ROA
1.7%
FCF Margin
1.7%
Balance Sheet & Liquidity
Current Ratio
1.26x
Quick Ratio
1.26x
Debt/Equity
3.68x
Debt/Assets
84.3%
Interest Coverage
N/A
Long-term Debt
1.6B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T10:08:43.346671 |
Data as of: 2026-03-31 |
Powered by Claude AI